26. HTLV-1関連脊髄症 HTLV-1-associated myelopathy Clinical trials / Disease details

臨床試験数 : 29 / 薬物数 : 47 - (DrugBank : 29) / 標的遺伝子数 : 34 - 標的パスウェイ数 : 119

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02655471 (ClinicalTrials.gov)	July 1, 2017	16/11/2015	Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Vir ...	Effect of Raltegravir in Patients With Myelopathy/Tropical Spastic Paraparesis Associated With Infec ...	HTLV-I Infections;Tropical Spastic Paraparesis	Drug: Raltegravir and Zidovudine	Universidad Peruana Cayetano Heredia	Merck Sharp & Dohme Corp.	Completed	18 Years	N/A	All	10	Early Phase 1	Peru
2	NCT00041327 (ClinicalTrials.gov)	October 2002	8/7/2002	Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With ...	Phase II Trial Of Induction Therapy With EPOCH Chemotherapy And Maintenance Therapy With Combivir/In ...	Lymphoma	Biological: filgrastim;Biological: recombinant interferon alfa;Drug: Etoposide;Drug: cyclophosphamid ...	AIDS Malignancy Consortium	National Cancer Institute (NCI)	Completed	18 Years	120 Years	Both	19	Phase 2	United States
3	NCT00272480 (ClinicalTrials.gov)	November 8, 1999	4/1/2006	Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial	Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial	HTLV-I-associated Myelopathy	Drug: Zidovudine /lamivudine;Drug: Placebos	Imperial College London	NULL	Completed	16 Years	75 Years	All	16	Phase 2/Phase 3	United Kingdom

First Previous1Next Last